Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
NCT01362621 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 474
Last updated 2011-06-16
Summary
The study was designed to collect data about inadequately controlled moderate to severe allergic asthma in subjects 6 to \< 12 years of age, managed in a real-world setting.
Conditions
- Moderate to Severe Allergic Asthma
Sponsors & Collaborators
-
Genentech, Inc.
collaborator INDUSTRY - lead INDUSTRY
Eligibility
- Min Age
- 6 Years
- Max Age
- 11 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-02-29
- Primary Completion
- 2010-02-28
Countries
- United States
- Puerto Rico
Study Locations
More Related Trials
-
Allergy Immunotherapy for the Reduction of Asthma
NCT01028560 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study With GW274150 In Patients With Mild Asthma
NCT00273013 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
NCT00267202 ·Status: COMPLETED ·Phase: PHASE4
-
Individualized Therapy For Asthma in Toddlers
NCT01606306 ·Status: COMPLETED ·Phase: PHASE3
-
Environmental Intervention Versus Standard Care to Reduce Pharmacologic Therapy for Asthma
NCT01593111 ·Status: COMPLETED ·Phase: NA
-
Effect of Heredity and Environment on Asthma Development and Severity in Puerto Rican Children
NCT00461227 ·Status: COMPLETED
-
Chronic Asthma Study in 2- to 5-Year-Old Patients (MK0476-072 )
NCT00968201 ·Status: COMPLETED ·Phase: PHASE3
-
Personalized Treatment Algorithms for Difficult-to-treat Asthma
NCT04179461 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up of Children With Severe Asthma at Adult Age
NCT05032209 ·Status: UNKNOWN
-
Home Based Environmental Adherence Trial
NCT00005523 ·Status: COMPLETED
-
Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED)
NCT00289874 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Risk Factors for Severe Asthma
NCT00090740 ·Status: COMPLETED
-
A Study Evaluating the Efficacy of QGE031 Compared to Omalizumab in Patients With Allergic Asthma
NCT01703312 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy and Safety of QGE031 Compared With Placebo in Patients Aged 18-75 Years With Asthma
NCT02336425 ·Status: TERMINATED ·Phase: PHASE2
-
Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma
NCT06317909 ·Status: RECRUITING ·Phase: NA
-
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
NCT01450774 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of 2 Doses of MAP0010 in Asthmatic Children
NCT00697697 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Combination of Beclomethasone Dipropionate and Formoterol Fumarate Versus Single Components Assessed by Knemometry and Urinary Cortisol Measurements in Asthmatic Children
NCT01658891 ·Status: WITHDRAWN ·Phase: PHASE3
-
Defining the Severe Paediatric Asthma Endotype
NCT04680117 ·Status: COMPLETED ·Phase: NA
-
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma
NCT00264849 ·Status: COMPLETED ·Phase: PHASE4
-
A Study To Evaluate The Treatment Pattern Of Moderate-to-Severe Asthma Patients In China
NCT06422663 ·Status: COMPLETED
-
Kinetics of IgE Memory B Cells, Plasmablasts and Plasma Cells After Whole Lung Allergen Challenge in Mild Asthmatics
NCT01420003 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Assessment of Children With Severe Asthma and Severe Pre-school Wheeze
NCT01982162 ·Status: COMPLETED
-
Efficacy, Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of Oral Administration of AIM-102 in Patients With Mild to Moderate Allergic Asthma
NCT01501942 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up of Mild Eosinophilic Asthma
NCT04650503 ·Status: UNKNOWN